drugset / Trial / NCT01117233
Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429
RandomizedParallel-groupDouble-blind
Summary
The purpose is to study the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-04427429 administered intravenously to healthy adult volunteers
Timeline
- Start
- 2010-05
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04427429 | Unknown | 10 mg | Intravenous |
| Subject | PF-04427429 | Unknown | 30 mg | Intravenous |
| Subject | PF-04427429 | Unknown | 100 mg | Intravenous |
| Subject | PF-04427429 | Unknown | 300 mg | Intravenous |
| Subject | PF-04427429 | Unknown | 1000 mg | Intravenous |
Indications
No indication recorded.